MedPath

NEOVACS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:5

Trial Phases

2 Phases

Phase 1:2
Phase 2:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (71.4%)
Phase 1
2 (28.6%)

Study of IFN-K in Dermatomyositis

Phase 2
Withdrawn
Conditions
Dermatomyositis
First Posted Date
2016-12-02
Last Posted Date
2020-01-03
Lead Sponsor
Neovacs
Registration Number
NCT02980198
Locations
🇨🇭

Research site, Lausanne, Switzerland

🇩🇪

Charité - Universitätsmedizin Berlin Rudolf- Virchow- Haus, Berlin, Germany

Phase IIb Study of IFN-K in Systemic Lupus Erythematosus

Phase 2
Terminated
Conditions
Systemic Lupus Erythematosus
First Posted Date
2016-01-27
Last Posted Date
2020-04-09
Lead Sponsor
Neovacs
Target Recruit Count
185
Registration Number
NCT02665364
Locations
🇹🇳

Research Site, Tunis, Tunisia

🇩🇪

Research site, Bad-Nauheim, Germany

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis

Phase 2
Completed
Conditions
Rheumatoid Arthritis
First Posted Date
2013-07-30
Last Posted Date
2019-03-22
Lead Sponsor
Neovacs
Target Recruit Count
143
Registration Number
NCT01911234
Locations
🇧🇪

Cliniques Universitaires Saint Luc, Brussels, Belgium

🇬🇪

"Acad. V. Tsitlanadze Scientific-Practical Center of Rheumatology" LLC, Tbilisi, Georgia

🇬🇪

"Medi Club Georgia" LLC, Tbilisi, Georgia

and more 28 locations

Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients

Phase 2
Completed
Conditions
Crohn's Disease
First Posted Date
2011-02-08
Last Posted Date
2014-09-18
Lead Sponsor
Neovacs
Target Recruit Count
66
Registration Number
NCT01291810
Locations
🇧🇪

Imelda Clinic, Bonheiden, Belgium

🇧🇪

Cliniques Universitaires St Luc, Brussels, Belgium

🇧🇪

Universitair Ziekenhuis Gent, Gent, Belgium

and more 55 locations

Safety of IFNa Kinoid in Systemic Lupus Erythematosus

Phase 1
Completed
Conditions
Systemic Lupus Erythematosus
First Posted Date
2010-01-28
Last Posted Date
2019-03-21
Lead Sponsor
Neovacs
Target Recruit Count
28
Registration Number
NCT01058343
Locations
🇧🇪

Cliniques Universitaires St Luc, Brussels, Belgium

🇧🇬

MHAT "Sveti Ivan Rilski", Sofia, Bulgaria

🇭🇷

University Hospital Split, Split, Croatia

and more 11 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.